Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Sangamo Therapeutics Inc (NASDAQ: SGMO) closed at $0.43 down -5.57%% from its previous closing price of $0.46. In other words, the price has decreased by -$5.57% from its previous closing price. On the day, 7.45 million shares were traded.
Ratios:
For a deeper understanding of Sangamo Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.76 and its Current Ratio is at 0.76. In the meantime, Its Debt-to-Equity ratio is 5.07 whereas as Long-Term Debt/Eq ratio is at 5.07.
On December 10, 2024, H.C. Wainwright reiterated its Buy ratingand also kept the price unchanged to $10.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 03, 2023, whereas the target price for the stock was revised from $6 to $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.66 while its Price-to-Book (P/B) ratio in mrq is 19.84.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -26.89%, while the 200-Day Moving Average is calculated to be -62.56%.
Shares Statistics:
A total of 245.40M shares are outstanding, with a floating share count of 237.34M. Insiders hold about 3.28% of the company’s shares, while institutions hold 21.61% stake in the company.
